PRA Health Sciences EPS beats by $0.16, beats on revenue; FY20 guidance

• PRA Health Sciences (NASDAQ:PRAH): Q3 Non-GAAP EPS of $1.30 beats by $0.16; GAAP EPS of $1.41 beats by $0.73.
• Revenue of $796.3M (+2.0% Y/Y) beats by $27.16M.
• FY20 guidance: Revenue of $3.120B-$3.150B vs consensus of $3.10B, GAAP net income per diluted share of $3.23-$3.35 and non-GAAP net income per diluted share of $4.61-$4.71 vs consensus of $4.46.
• Press Release
• https://seekingalpha.com/news/3631464-pra-health-sciences-eps-beats-0_16-beats-on-revenue-fy20-guidance